Eni SpA vs UnitedHealth Group Inc — how do they compare? Eni SpA trades at $55.41 (market cap $79.81B), while UnitedHealth Group Inc trades at $371.5 (market cap $337.48B). The key difference: UnitedHealth Group Inc is far larger — about 4.2× Eni SpA's market cap, and Eni SpA pays the higher dividend (4.39%). Which is the better fit depends on your goals — on Pluang, investors hold Eni SpA for 53 Days and UnitedHealth Group Inc for 97 Days on average.
| E | UNH | |
|---|---|---|
Market Cap | $79.81B | $337.48B |
Volume | 365,912 | 5,620,541 |
Sector | Energy | Health |
52-Week High | $57.61 | $436.35 |
52-Week Low | $34.03 | $259.02 |
Typical Hold Time | 53 Days | 97 Days |
Enterprise Value | $104.34B | $379.34B |
Dividend Yield | 4.39% | 2.47% |
Signals from Pluang's Aura AI — not financial advice
Eni (E) trades at $53.96, down 1.08% on the day, amid a bearish technical signal and mixed earnings performance. Revenue has declined from $132.5B in 2022 to $82.15B in 2025, though net income margin improved to 5.97%. Recent news highlights strategic moves in humanoid robotics, LNG projects, and fuel discounts. The stock shows attractive valuation with a P/E of 12.87 and P/S of 0.85, while cash flow remains positive but net cash flow turned negative in 2026 projections.
The outlook is cautious; low valuations and dividend payments offer value, but revenue declines and earnings misses pose risks. Analyst consensus is mixed with 34.62% buy ratings. Key risks include energy price volatility and execution of new tech initiatives. Further upside depends on stabilizing revenue and meeting earnings expectations.
UnitedHealth Group (UNH) trades at $370.95, down 1.43% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats and a raised 2026 outlook highlight fundamental strength, though net income margins have compressed. The stock is supported by a $2.32 dividend payment scheduled for September 22, 2026, and positive sentiment around Medicare Advantage and Optum growth.
The outlook remains positive with an 82.7% analyst buy rating and a $473.89 consensus price target, implying significant upside. Key risks include regulatory pressures and medical cost trends, but strategic AI investments and solid cash flow support long-term growth. Investors should weigh the attractive valuation against execution risks in a dynamic healthcare landscape.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →